Stay updated with breaking news from Updated Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Multiple epcoritamab (DuoBody-CD3xCD20) studies will be presented showcasing preliminary efficacy and safety findings in a variety of patient populations in need of treatment options Several
Data from NOVA study further support the efficacy and safety of natalizumab IV when administered every six weeks as compared to the approved every four-week dosingAdditional real-world data affirm high
Data from NOVA study further support the efficacy and safety of natalizumab IV when administered every six weeks as compared to the approved every...
It is not known at this time if this year's report to Congress will alter the projected year of HI depletion./ 2. The decline of HI's reserves is of course, on its own, a problem that should concern Congress because of the importance of ensuring continuity in the provision of medical services. Congress has never allowed such a scenario to occur, and it is unlikely to do...
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new analyses illustrating responses that first-line treatment with...